Sunshine Biopharma Inc. Com New
13F holders, Q1 2024 (March 31)1holders
$0.06avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Sunshine Biopharma Inc. Com New in their 13F filings. The largest holder was Rise Advisors, LLC ($1).
- Company
- Sunshine Biopharma Inc. Com New
- CUSIP
- 867781304
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Rise Advisors, LLC | 0.00% | No change | 18 | $1 |
"% of holder's portfolio" is SUNSHINE BIOPHARMA INC COM NEW's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. Com New the manager owns.